Volume : 09, Issue : 08, August – 2022
Title:
16.FLOATING MICROSPHERES ENCAPSULATING CARVEDILOL FOR EFFECTIVE MANAGEMENT OF HYPERTENSION
Authors :
Mahak Modi*, Mradul Kumar Jain, Megha Shrivastava, Shikha Mishra, Shubham Chourasiya
Abstract :
The objective of the present study was to formulate and evaluate floating microspheres of carvedilol. Carvedilol has a terminal half-life of 7-10 hr, but most of the drug is eliminated with a half-life of about 2hr.Besidesbeingabeneficialdrugcomparedtoother drugs of the same class, it has narrow absorption window in upper part of the gastro intestinal tract, hence a floating drug delivery system is preferred, such that the formulation will be available for a longer duration than usual for absorption. Floating microspheres were prepared by emulsion solvent diffusion method using ethanol and dichloromethane as solvents. Ethyl cellulose and Hydroxy propyl methyl cellulose, HPMC K 4 M, were used to prolong the release of the drug from microspheres. The prepared microspheres were subjected to various evaluatory studies. All the microspheres were found to have a size in the range of 20-40 μ and were nearly spherical in shape. For optimization of Formulation F1 (EudragitRS100), F2 (Acrycoat S 100) and F3 (Cellulose Acetate) was selected. The formulation F1 prepared using EudragitRS100 showed 82.5±2.76 percentage drug release AFTER 24 Hrs. as compare to other formulations.
Key words: Carvedilol, Floating microspheres, Hypertension
Cite This Article:
Please cite this article in press Mahak Modi et al, Floating Microspheres Encapsulating Carvedilol For Effective Management Of Hypertension., Indo Am. J. P. Sci, 2022; 09(8).
,
Number of Downloads : 10
References:
1. Roy P, Shahiwala A. Multiparticulate formulation approach to pulsatile drug delivery: A current perspectives. Journal of Controlled Release. 2009; 134(2): 74-80.
2. Dehghan Mohamed HG, Khan FN. Gastroretentive Drug Delivery Systems: A Patent Perspective. International Journal of Health Research. March 2009; 2(1): 23-44.
3. Nayak AK, Maji R, Das B. Gastro retentive drug delivery systems: A review. Asian Journal of Pharmaceutical and Clinical Research. 2010; 3(1): 1-10.
4. Emeje MO, Kunle OO. Compaction characteristics of ethyl cellulose in presence of some channeling agent: technical note. AAPS Pharm SciTech. 2006; 7 (3): article58.
5. Avachat AM, Patel KB, Rokade MS, Dash RR. Formulation and characterization of an expandable gastroretentive system of carvedilol phosphate by 32 factorial design. PDA J Pharm Sci Technol 2011;65:12-9.
6. Chakraborty S, Shukla D, Jain A. Assessment of solubilization characteristics of different surfactants for carvedilol phosphate as a function of pH. J Colloid Interface Sci 2009;335:242-9.
7. Agrawal SS, Aggarwal A. Randomised, cross-over, comparative bioavailability trial of the matrix type transdermal drug delivery system of carvedilol and hydrochlorothiazide combination in healthy human volunteers: a pilot study. Contemporary Clin Trials 2010;31:272-8.